SCHEMBL7535546

SCHEMBL7535546

Cc1cccc(C(=O)N[C@@H](CC2CCCCC2)C(=O)N(C)C#N)c1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CTSL P07711 11/20 0.54
CTSS P25774 9/20 0.54
CTSB P07858 5/20 0.54
CTSK P43235 4/20 0.54
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
POLB P06746 1/20 0.46
KMT2A Q03164 1/20 0.46
GPR132 Q9UNW8 1/20 0.44
GRN P28799 1/20 0.43
SORT1 Q99523 1/20 0.43
CTSV O60911 1/20 0.43
LMNA P02545 1/20 0.43
TAS1R3 Q7RTX0 1/20 0.42
TAS1R1 Q7RTX1 1/20 0.42
USP30 Q70CQ3 1/20 0.42
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7562349 0.90 CTSL (0.54) CTSLCTSSCTSBCTSKKMT2A
SCHEMBL5523605 0.89 CTSL (0.53) CTSLCTSSCTSBCTSKRAB9A
SCHEMBL5522774 0.89 CTSS (0.53) CTSLCTSSCTSBCTSKNPC1
SCHEMBL7567919 0.89 USP30 (0.54) CTSLCTSSCTSBCTSKKMT2A
SCHEMBL5525335 0.88 CTSL (0.69) CTSLCTSSCTSBCTSKGRN
SCHEMBL5530441 0.88 CTSL (0.69) CTSLCTSSCTSBCTSKGRN
SCHEMBL7539325 0.88 CTSS (0.54) CTSLCTSSCTSBCTSKNPC1
SCHEMBL5520686 0.88 CTSL (0.58) CTSLCTSSCTSBCTSKGPR132
SCHEMBL6590402 0.86 CTSL (0.51) CTSLCTSSCTSBCTSKNPC1
SCHEMBL5525443 0.85 CTSL (0.55) CTSLCTSSCTSBCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1178958-A2 N-CYANOMETHYL AMIDES AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-02-13 EP disclosed
WO-2000055125-A2 N-CYANOMETHYL AMIDES AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2000-09-21 WO disclosed